Stay updated with breaking news from Director Eric Andersen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Free Report) Director Eric Andersen acquired 134,493 shares of the company’s stock in a transaction that occurred on Monday, August 7th. The shares were acquired at an average cost of $12.00 per share, for a total transaction of $1,613,916.00. Following the purchase, the director now directly owns 1,496,680 shares […]
StockNews.com upgraded shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) from a sell rating to a hold rating in a research report released on Saturday morning. Merrimack Pharmaceuticals Stock Up 0.3 % MACK opened at $12.81 on Friday. The firm has a market capitalization of $182.67 million, a P/E ratio of -106.75 and a beta […]
Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued on Saturday. Merrimack Pharmaceuticals Price Performance Merrimack Pharmaceuticals stock opened at $12.50 on Friday. The stock has a market cap of $178.25 million, a P/E ratio of -104.17 and […]
StockNews.com upgraded shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) from a sell rating to a hold rating in a report published on Thursday morning. Merrimack Pharmaceuticals Stock Up 0.6 % Shares of NASDAQ MACK opened at $12.62 on Thursday. Merrimack Pharmaceuticals has a 12-month low of $3.00 and a 12-month high of $13.66. The […]
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Rating)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $9.67 and traded as high as $12.66. Merrimack Pharmaceuticals shares last traded at $12.51, with a volume of 63,141 shares trading hands. Analysts […]